Global CT Market Size, Share, Trends & Growth Forecast Report – Segmented By Low-slice Type (Single Slice and Dual Slice), Slice Type (6 Slice, 10 Slice, 16 Slice and 32 Slice), High-slice Type (40 Slice, 64 Slice, Open Versions and Cardiac CT), End-Users and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Industry Analysis From 2024 to 2033
The global CT market is estimated to grow from USD 7.53 billion in 2024 to USD 11.23 billion in 2033, representing a CAGR of 4.54%.

The Computed Tomography (CT) is a non-invasive imaging modality that utilizes X-ray technology and computer reconstruction to generate cross-sectional and three-dimensional visualizations of internal anatomical structures. It plays a pivotal role in diagnosing cardiovascular conditions, oncological staging, trauma assessment, and neurological disorders.
The escalating global burden of chronic diseases such as cancer and cardiovascular conditions is driving the growth of the Computed Tomography (CT) market. According to the International Agency for Research on Cancer, an estimated 20 million new cancer cases were diagnosed globally in 2022. According to the Global Burden of Disease Study, ischemic heart disease remains the leading cause of death worldwide, with CT coronary angiography increasingly replacing invasive procedures for early detection. As per the Centers for Disease Control and Prevention, more than 15 million CT scans are performed annually for cardiac and vascular assessment. This growing clinical dependency on high-resolution anatomical imaging ensures sustained demand for advanced CT systems across acute and preventive care settings.
The integration of CT scanning into emergency medicine has become standard practice in trauma centers, which is significantly propelling the growth of the Computed Tomography (CT) market. In scenarios such as head injuries, internal bleeding, or stroke, CT provides rapid, high-accuracy imaging essential for timely intervention. In India, the National Health Mission has equipped over 300 district hospitals with CT scanners since 2020 to strengthen emergency care under the National Trauma Care System.
The persistent concerns over ionizing radiation exposure is restraining the growth of the Computed Tomography (CT) market. A single abdominal CT scan delivers a radiation dose equivalent to 300 chest X-rays, increasing cumulative cancer risk in pediatric and young adult populations. According to the National Cancer Institute, it is estimated that 2% of all cancer cases in the U.S. could be attributable to CT scan radiation exposure. According to a 2023 audit by the Radiological Society of North America, nearly 25% of outpatient CT facilities still exceed recommended dose thresholds. These safety concerns necessitate rigorous oversight, which is limiting scan frequency and influencing clinical decision-making.
The financial burden associated with purchasing and operating high-end CT scanners restricts accessibility in low- and middle-income countries and rural healthcare settings is limiting the growth of the Computed Tomography (CT) market. Additional expenses include shielding infrastructure, power stabilization, and trained radiology personnel.
Artificial intelligence is transforming CT imaging by enhancing diagnostic accuracy by reducing interpretation time, and optimizing operational efficiency is to create new opportunities for the growth of the Computed Tomography (CT) market. AI-powered algorithms can automatically detect pulmonary nodules, intracranial hemorrhages, and coronary artery calcifications with high sensitivity. The U.S. Food and Drug Administration has cleared over 500 AI algorithms for medical imaging, including more than 80 specifically for CT applications.
The deployment of mobile and compact CT scanners is expanding access to advanced imaging in remote, underserved, and emergency field environments is additionally to fuel the growth of the Computed Tomography (CT) market. Portable head CT units, such as the Hyperfine Swoop system, operate on standard power outlets and are being used in intensive care units and stroke units to avoid patient transport risks. In rural India, the Indian Council of Medical Research has deployed mobile CT vans across seven states, conducting over 120,000 scans since 2021 for stroke and trauma assessment. The European Union’s Horizon 2020 program funded the development of a lightweight, transportable CT unit for battlefield and disaster response, demonstrating feasibility in austere conditions.
The shortage of skilled radiologists and CT technologists is acting as barrier for the growth of the Computed Tomography (CT) market. Even in developed regions, workforce strain is evident. According to the American College of Radiology, a deficit of 7,500 radiologists in the U.S. by 2030. As per 2023 survey by the European Society of Radiology, 45% of radiologists work beyond contracted hours to manage CT workload, increasing burnout and diagnostic errors. Training programs remain limited; only 18 countries have formal CT technology certification curricula recognized by the International Atomic Energy Agency.
The disparities in regulatory approval timelines and reimbursement policies is additionally to hamper the growth of the Computed Tomography (CT) market. While advanced systems receive FDA clearance in the U.S. within 6–9 months, approval in countries like Brazil or Indonesia can take over two years due to fragmented regulatory frameworks, as noted by the Global Harmonization Task Force. Reimbursement inconsistencies further complicate access; in Germany, CT angiography is fully covered under statutory health insurance, whereas in Poland, patients often face out-of-pocket costs exceeding €300 per scan, discouraging utilization. The Organisation for Economic Co-operation and Development reports that only 12 of 38 member countries have standardized national guidelines for appropriate CT use, leading to overutilization in some regions and underuse in others.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Slice Type, Low-slice Type, High-slice Type, End Users, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leader Profiled | G.E. Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation |
The Single slice CT segment was accounted in holding a prominent share of the Computed Tomography (CT) market in 2024 with its widespread deployment in primary care clinics, rural health centers, and outpatient imaging facilities where cost-efficiency and operational simplicity are paramount. According to the World Health Organization, over 40% of diagnostic imaging units in low- and middle-income countries consist of single slice CT scanners in Sub-Saharan Africa and South Asia. These systems are routinely used for basic neuroimaging, trauma evaluation, and pulmonary diagnostics. Additionally, their lower power requirements and minimal infrastructure needs enable installation in non-traditional medical environments, such as mobile clinics and field hospitals, further solidifying their role in expanding basic imaging access.

The Dual slice CT segment is likely to grow with an expected CAGR of 5.7% during the forecast period with its ability to deliver improved temporal resolution and faster scan times compared to single slice systems by enabling better visualization of moving structures such as the heart and lungs. Dual slice scanners can perform helical acquisitions with reduced motion artifacts, making them suitable for emergency departments in mid-tier hospitals. As per the Radiological Society of India, over 1,200 dual slice units were installed in tier-2 and tier-3 Indian cities between 2020 and 2023 to support stroke and chest imaging programs.
The 16 slice CT segment held 44.3% of the Computed Tomography (CT) market share in 2024 with the optimal balance between imaging performance, cost, and clinical versatility. Sixteen slice systems are capable of coronary calcium scoring, pulmonary angiography, and multi-phase abdominal imaging by making them suitable for comprehensive diagnostic workflows in community hospitals and private imaging centers. According to the American College of Cardiology, 16 slice CT scanners are used in over 60% of non-invasive cardiac screening programs in outpatient settings across the U.S. In Europe, the European Society of Radiology notes that 16 slice units form the backbone of regional imaging networks in countries like Spain and Poland, where they serve populations of 200,000–500,000. Their ability to generate diagnostic-quality images with moderate radiation dose and compatibility with iterative reconstruction software has cemented their status as a clinical workhorse in mid-capacity healthcare environments.
The 32 slice CT segment is projected to grow at a CAGR of 6.9% throughout the forecast period owing to the rising demand for faster scanning and improved cardiac and vascular imaging capabilities. They are increasingly used for CT angiography, allowing non-invasive assessment of coronary, carotid, and peripheral arteries. In Japan, the Ministry of Health, Labour and Welfare reports that 32 slice CT units are deployed in over 70% of secondary care hospitals for stroke and cardiac triage. The system’s ability to perform whole-organ perfusion studies and dynamic contrast imaging has expanded its utility in oncology and interventional radiology.
The 64 slice CT segment dominated the Computed Tomography (CT) market with 52.8% of the share in 2024 with its unparalleled capability in cardiovascular, oncological, and trauma imaging, making it indispensable in tertiary care and academic medical centers. Sixty-four slice systems enable sub-millimeter isotropic resolution, allowing detailed 3D reconstructions of coronary arteries and microvasculature.
The Cardiac CT segment is anticipated to grow with an estimated CAGR of 8.3% in the next coming years with the rising global burden of cardiovascular disease and the shift toward non-invasive diagnostic methods. Cardiac CT allows precise assessment of coronary artery disease, plaque composition, and myocardial perfusion without the risks associated with catheterization. The European Society of Cardiology states that cardiac CT is now recommended as a first-line test for stable chest pain in its clinical guidelines, significantly increasing referral volumes.

North America was the largest contributor with a 39.4% of the Computed Tomography (CT) market share in 2024 with its advanced healthcare infrastructure, high per capita imaging utilization, and early adoption of cutting-edge technologies. The United States performs over 80 million CT scans annually, averaging more than 240 scans per 1,000 population, according to the Centers for Disease Control and Prevention. Reimbursement support from Medicare and private insurers facilitates widespread access, while the presence of major manufacturers such as GE Healthcare, Siemens Healthineers, and Canon Medical ensures rapid technology diffusion.
Europe was ranked second with 28.6% of the Computed Tomography (CT) market share in 2024. Countries such as Germany, France, and the UK have well-established imaging networks with high scanner density. Germany averages 42 CT units per million population, which is one of the highest in the world, as per Eurostat. The EU’s Basic Safety Standards Directive mandates dose monitoring and quality assurance, ensuring patient safety and standardization. The European Society of Radiology’s EuroSafe Imaging campaign has led to a 25% reduction in average CT radiation dose since 2011. Public healthcare systems prioritize cost-effective mid-slice systems, while academic centers invest in 64 slice and spectral CT for research.
The Asia Pacific CT market growth is anticipated to have significant CAGR during the forecast period with the rapid expansion driven by healthcare modernization and government investment. Japan and South Korea lead in technology adoption, with Japan’s Pharmaceuticals and Medical Devices Agency clearing over 120 CT-related innovations since 2020. In China, the National Health Commission has launched the “Healthy China 2030” initiative, which includes the installation of 10,000 new CT scanners in county-level hospitals by 2025. India’s National Digital Health Mission has facilitated the deployment of over 1,500 CT units in rural areas since 2021, as reported by the Ministry of Health.
Latin America Computed Tomography (CT) market is likely to have a steady growth opportunities in the next coming years. Brazil and Mexico are the primary markets, with Brazil operating over 1,800 CT scanners, according to ANVISA, the national health regulator. However, scanner distribution is highly skewed, with 70% concentrated in urban centers. Public-private partnerships, such as Argentina’s ProSALUD program, are expanding access to mid-slice CT in provincial hospitals. Regulatory streamlining and technology leasing models are emerging as enablers of broader adoption in this developing market.
The Middle East and Africa Computed Tomography (CT) market is expected to have slow growth opportunities. Gulf Cooperation Council (GCC) nations such as the UAE and Saudi Arabia are investing heavily in smart healthcare; the UAE’s Ministry of Health and Prevention has allocated $900 million for diagnostic imaging modernization between 2021 and 2026. Saudi Arabia’s Vision 2030 includes the deployment of 500 new CT units across its national healthcare network
Companies leading the Global CT market profiled in the report are G.E. Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation.
The competition in the CT market is characterized by a convergence of technological innovation, regulatory agility, and strategic regional expansion. Established players such as GE Healthcare, Siemens Healthineers, and Canon Medical Systems dominate through advanced hardware, AI integration, and comprehensive service networks, while emerging vendors are challenging with cost-optimized systems for mid-tier hospitals. The Asia Pacific region has become a strategic battleground, with manufacturers tailoring solutions to varying infrastructure levels and disease profiles.
GE Healthcare
GE Healthcare has dominant presence in the Asia Pacific CT market through continuous innovation and localized deployment strategies. The company’s Revolution series of CT scanners, including the Revolution Apex and Revolution CT, are widely installed in major hospitals across Japan, South Korea, India, and Australia, offering high-speed imaging with low radiation dose. The company also partnered with India’s Apollo Hospitals to integrate its CT systems with AI-powered analytics for cardiac and oncology workflows.
Siemens Healthineers
Siemens Healthineers has demonstrated strong engagement in the Asia Pacific market by advancing its high-performance CT platforms tailored to regional clinical demands. Its SOMATOM Force and SOMATOM Drive scanners are deployed in leading institutions such as Japan’s National Cancer Center and Thailand’s Siriraj Hospital, supporting cardiac, oncological, and emergency imaging. In 2022, Siemens introduced the myExam Companion, an AI-driven workflow assistant, in over 150 facilities across Australia and South Korea, improving scan consistency and reducing operator dependency. The company also collaborated with Taiwan’s Chang Gung Memorial Hospital to optimize spectral CT applications for liver lesion characterization.
Canon Medical Systems
Canon Medical Systems has significantly expanded its footprint in the Asia Pacific CT market by emphasizing technological precision, dose efficiency, and sustainability. Its Aquilion series, which is including the Aquilion ONE / GENESIS and Aquilion PRISM, are extensively used in Japan, South Korea, and India for cardiovascular and neurological imaging. In 2023, Canon launched the Advanced intelligent Clear-IQ Engine (AiCE), a deep-learning reconstruction technology, across 300+ hospitals in the region, enabling diagnostic confidence at ultra-low radiation doses. The company also partnered with Australia’s Royal Brisbane and Women’s Hospital to implement spectral CT for renal stone characterization and tumor differentiation.
Key players in the CT market are employing multifaceted strategies to consolidate their influence and drive technological adoption. Companies are prioritizing artificial intelligence integration to enhance image reconstruction, reduce radiation dose, and streamline radiology workflows. Strategic partnerships with academic hospitals and research institutions enable real-world validation and clinical protocol development. Firms are investing in hybrid solutions, such as spectral and dual-energy CT, to differentiate their offerings in competitive tenders. Service expansion, including remote monitoring, predictive maintenance, and training programs, strengthens customer retention. Additionally, vendors are focusing on modular system designs and financing models to improve accessibility in emerging markets by ensuring long-term scalability and operational resilience in diverse healthcare ecosystems
This research report on the global CT market has been segmented and sub-segmented into the following categories.
By Low-slice Type
By Slice Type
By High-slice Type
By End-Users
By Region
Frequently Asked Questions
As per our research report, the global CT market size is projected to value at USD 10.74 billion by 2032.
Yes, we have studied and included the COVID-19 impact on the global CT market in this report.
Geographically, the North American regional market accounted for the largest share of the global CT market in 2023.
GE Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation are some of the notable companies operating in the global CT market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region